Edition:
United Kingdom

Summit Therapeutics PLC (SMMT.OQ)

SMMT.OQ on NASDAQ Stock Exchange Global Market

12.56USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$12.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,469
52-wk High
$16.59
52-wk Low
$8.80

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.11 32.75
P/E High - Last 5 Yrs. -- 293.49 45.73
P/E Low - Last 5 Yrs. -- 91.70 24.23
Beta -- 0.90 0.88
Price to Sales (TTM) -- 111.03 5.71
Price to Book (MRQ) -- 13.59 5.37
Price to Tangible Book (MRQ) -- 14.06 6.94
Price to Cash Flow (TTM) -- 71.48 23.33
% Owned Institutions -- 12.72 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.73 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.57 7.90
Sales (TTM) vs TTM 1 Yr. Ago -- 78.92 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 25.13 19.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.04 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.32 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) -- 5.30 2.98
LT Debt to Equity (MRQ) -- 22.94 12.17
Total Debt to Equity (MRQ) -- 24.60 16.44
Interest Coverage (TTM) -- -99.47 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.19 52.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.11 10.97
Operating Margin (TTM) -- -719.50 4.73
Operating Margin - 5 Yr. Avg. -- -596.43 6.40
Pre-Tax Margin (TTM) -- -693.95 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.75 6.82
Net Profit Margin (TTM) -- -695.17 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.23 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,647,969 847,045,629
Net Income/Employee (TTM) -- 2,975,306 99,641,512
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) -- 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.10 10.95
Return on Assets - 5 Yr. Avg. -- -0.58 12.32
Return on Investment (TTM) -- 1.56 14.38
Return on Investment - 5 Yr. Avg. -- 2.22 16.11
Return on Equity (TTM) -- 2.43 16.07
Return on Equity - 5 Yr. Avg. -- 3.12 17.39

Performance for Summit Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.